Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) EVP Sells 30,000 Shares of Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Ryan Specialty Stock Performance

RYAN stock opened at $71.08 on Wednesday. The firm has a market cap of $18.62 billion, a price-to-earnings ratio of 103.01, a PEG ratio of 1.19 and a beta of 0.71. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97. The business’s fifty day simple moving average is $67.51 and its two-hundred day simple moving average is $67.86.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were issued a $0.12 dividend. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty’s payout ratio is presently 69.57%.

Institutional Trading of Ryan Specialty

Institutional investors and hedge funds have recently made changes to their positions in the company. Jennison Associates LLC raised its holdings in shares of Ryan Specialty by 60.2% in the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after acquiring an additional 385,366 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Ryan Specialty by 107.5% in the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock valued at $30,504,000 after purchasing an additional 238,064 shares during the last quarter. Bar Harbor Wealth Management grew its stake in Ryan Specialty by 5.9% in the fourth quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock valued at $10,835,000 after purchasing an additional 9,482 shares during the last quarter. Barclays PLC grew its stake in Ryan Specialty by 1.1% in the third quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock valued at $108,994,000 after purchasing an additional 17,267 shares during the last quarter. Finally, Crossmark Global Holdings Inc. purchased a new position in Ryan Specialty in the third quarter valued at about $475,000. 84.82% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

RYAN has been the topic of several recent research reports. Barclays increased their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, November 21st. Morgan Stanley initiated coverage on Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target on the stock. Royal Bank of Canada decreased their price target on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday, February 21st. UBS Group increased their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Finally, Wells Fargo & Company increased their price target on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and a consensus price target of $75.27.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.